Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 6 studies | 23% ± 6% | |
| epithelial cell | 6 studies | 22% ± 6% | |
| fibroblast | 4 studies | 22% ± 6% | |
| natural killer cell | 4 studies | 22% ± 9% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 17% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 4 studies | 18% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 2474.51 | 258 / 258 | 100% | 23.68 | 230 / 230 |
| esophagus | 100% | 2696.94 | 1445 / 1445 | 100% | 14.47 | 183 / 183 |
| liver | 100% | 1741.26 | 226 / 226 | 100% | 17.77 | 406 / 406 |
| pancreas | 100% | 1278.91 | 328 / 328 | 100% | 28.04 | 178 / 178 |
| stomach | 100% | 1838.17 | 359 / 359 | 100% | 21.81 | 286 / 286 |
| brain | 100% | 2380.47 | 2641 / 2642 | 100% | 21.06 | 705 / 705 |
| thymus | 100% | 2685.30 | 653 / 653 | 100% | 23.37 | 604 / 605 |
| intestine | 100% | 2619.13 | 966 / 966 | 100% | 23.15 | 525 / 527 |
| uterus | 100% | 2945.28 | 170 / 170 | 100% | 25.17 | 457 / 459 |
| kidney | 100% | 2719.08 | 89 / 89 | 100% | 19.92 | 897 / 901 |
| prostate | 100% | 3228.41 | 245 / 245 | 99% | 20.76 | 499 / 502 |
| skin | 100% | 2123.50 | 1809 / 1809 | 99% | 21.41 | 469 / 472 |
| bladder | 100% | 2742.52 | 21 / 21 | 99% | 23.39 | 500 / 504 |
| lung | 100% | 2653.53 | 577 / 578 | 99% | 17.95 | 1144 / 1155 |
| breast | 100% | 2454.63 | 459 / 459 | 98% | 19.04 | 1100 / 1118 |
| ovary | 100% | 2575.11 | 180 / 180 | 97% | 12.71 | 419 / 430 |
| adipose | 100% | 2322.79 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 21.26 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 28.01 | 29 / 29 |
| spleen | 100% | 4048.24 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 21.34 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 15.28 | 1 / 1 |
| blood vessel | 100% | 2348.69 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 100% | 2154.27 | 860 / 861 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1570.38 | 802 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 97% | 1563.83 | 901 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007165 | Biological process | signal transduction |
| GO_0042147 | Biological process | retrograde transport, endosome to Golgi |
| GO_0006886 | Biological process | intracellular protein transport |
| GO_0043001 | Biological process | Golgi to plasma membrane protein transport |
| GO_0007369 | Biological process | gastrulation |
| GO_0034067 | Biological process | protein localization to Golgi apparatus |
| GO_0032588 | Cellular component | trans-Golgi network membrane |
| GO_0005802 | Cellular component | trans-Golgi network |
| GO_0005829 | Cellular component | cytosol |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0016020 | Cellular component | membrane |
| GO_0005525 | Molecular function | GTP binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003924 | Molecular function | GTPase activity |
| Gene name | ARFRP1 |
| Protein name | ADP-ribosylation factor-related protein 1 ADP-ribosylation factor-related protein 1 (ARF-related protein 1) (ARP) |
| Synonyms | ARP1 |
| Description | FUNCTION: Trans-Golgi-associated GTPase that regulates protein sorting. Controls the targeting of ARL1 and its effector to the trans-Golgi. Required for the lipidation of chylomicrons in the intestine and required for VLDL lipidation in the liver. . FUNCTION: Trans-Golgi-associated GTPase that regulates protein sorting. Controls the targeting of ARL1 and its effector to the trans-Golgi. Required for the lipidation of chylomicrons in the intestine and required for VLDL lipidation in the liver. . |
| Accessions | ENST00000619493.4 [Q13795-1] ENST00000607873.1 [Q13795-3] Q13795 ENST00000618838.4 [Q13795-1] ENST00000612256.4 [Q13795-3] ENST00000612157.4 [Q13795-2] ENST00000614942.4 [Q13795-4] ENST00000622789.5 [Q13795-1] B7ZKY8 ENST00000618568.4 [Q13795-4] |